SlideShare a Scribd company logo
1 of 71
GUIDED BY : DR. C. GADKARI MAM
PRESENTED BY : DR. ANURAG GIRI
 Located in rt upper quadrant of the abdomen
under right lower rib cage and projects for a
variable extent into left upper quadrant
 Held in place by ligamentous attachment to the
diphram, peritonium ,great vessles and upper GI
track.
 Rt lobe further divided into: 1. CAUDATE
POSTERIOR SURFACE
 2. QUADRATE INFERIOR SURFACE
 Liver is divided into 8 segments
 Largest internal organ and body’s metabolic
headquarter
 Wt. 1.5kg (2%)of total body weight of adult
 Liver receives 25% of cardiac output via dual supply
(portal vein and hepatic artery)
 Portal vein drains blood from GI track and supply 75%
of liver inflow (1L/min)
 Hepatic artery supply 25%
 Due to high O2 contents in hepatic artery each vessel
supply 50% of hepatic O2
 Portal vein have low vascular resistance (8-10mm/hg)
 Hepatic venous pressure is 0 mm/hg
 Functional unit Is lobule (1x2mm). 50,000-
1,00,000
 Lobule consists of plates of hepatocytes located in
a radial distribution about a central vein
 Efferent blood supply from portal vein and hepatic
arterey enters at periphery of lobule
 Bile formed in the hepatocytes flows into canaliculi
(located between plates of hepatocytes) and
drains to the bile duct
 The large pores in the endothelium lining are
sinusoids lined by two types of cell : typical
endothelial cells and large kupffer cells(reticulo
endothelial) capable of pagocytizing bacteria and
other foreign matter in the blood. Allow plasma
and its protein to move into the tissue space
surrounding hepatocytes (space of dissc) This
fluid drains into the lymphatic system
 Microcirculation of liver lobule
 ZONE 1: PERIPORTEL : Receive O2 rich blood
from portal vein and hepatic artery.
 ZONE 2: MEDIOLOBULAR : As blood moves
through sinusoid it passes from zone 2 to zone 3.
 ZONE 3: CENTRILOBULAR : Poor in O2
 Sympathetic innervation from T3 to T11 controls
resistance in hepatic venules
 When injured hepatocytes turns into fibrous tissue
blood flow is impeded and causes portal
hypertension
 When portal venous flow is reduced the hepatic
atrery can increase flow by 100% to maintain
hepatic O2 supply.This relation between two
vesseles is hepatic artrial buffer response
FUNCTION DETAILS ANAESTHETIC
RELEVANCE
BLOOD RESERVOIR 10-15% of total blood
volume
Anaesthetics supress
sympathetic tone
BLOOD COAGULATION Synt of pro and
anticlotting.vit K
absorption depends on
bile excretion.
Thrombopoietin
modulates platelet
production
Coagulopathies lead
to increased
perioperative
bleeding
ENDOCRINE CONTROL Syn & secretes Insuline
like growth
factor1,angiotensin,
Thyroxine binding
globulin Converts T4 to
T3. inactivates:
corticosteroids,
aldosteron, estrogen,
androgen, insulin, ADH
Perioperative
endocrine
abnormalities
BILIRUBIN
EXCRETION
Absorbs bilirubin
from
blood,conjugates and
excretes.synthesizes
haptoglobin and
scavenges Hb
Lipid metabolism Fatty acid synthesis,
cholesterol and
lipoprotein metabolism
Abnormal cellular
function, affect
pharmacokinetic and
dynamics of anaesthetic
agents.
Amino acid metabolism Protein and aminoacid
metabolism and urea
production
Elevated level and
encephalopathy
Immunologic modulation Largest
reticuloendothelial organ.
Filters out toxins,
bacteria and debris.
Hepatic
macrophages,Tcells and
Kupffer cells triggers
systemic inflammatory
Immunocompromise
susceptible to
perioperative infection
and sepsis.
 Liver can store 1L of blood and release blood in
circulation at low blood volume
 Liver stores vit.B12 (1yr supply)
 vit.D (3mnth supply)
 vit.A (10mnth supply)
 Iron transported via apoferrin and stored as ferritin
(blood iron buffer
 Energy production and storage of nutrients
absorbed from GI track
 Glucose buffering function : Store glucose as
glycogen convert carbohydrate (fructose and
glactose) to glucose
 Synthesise glucose from amino acid and
triglicerides (gluconeogenesis)
 Synthesise fat cholesterol phospholipids and lipo
proteins
 Metabolise fat,convert fatty acid to acetyl
coenzyme A (COA) is excellent source of energy
 Cholestrol synthesized is converted to bile salt
and secreted to bile,rest is distributed to body to
form cellular membrane and other vital structure
 Protein metabolism synthesize all plasma protein
except gama globolins (which are formed in
plasma cell)
 Forms 15-50gms protein/day
 Albumin is the major protein synthesized and
responsible for plasma oncotic pressure
 Blood clotting factors
 Synthesize in liver except factor III (tissue
thromboplastin), factor IV (calcium) and factor VIII
(von willbrand)
 Vit K is required for synthesis of factor II
(prothombin),factor VII , IX , X
 Produce around 500ml of bile daily and store in gall
bladder in concentrated form 35-50ml
 The fat in food in the duodeneum causes release of
choleystokenin hormone from duodenel mucose that
stimulate gall bladder contraction
 Bile contains bile salt,bilirubin and cholestrol.
 It dissolves fat to absorb into GI track and bile salt
returns to liver by portal vein
 Liver has unique ability to regenerate
 It restores itself after injury or partial hepatectomy
 Hepatocytes growth factor produced by
mesenchymal cells in the liver
 Other growth factor are epidermal growth factor,
interlukin-6,cytokines ,tumor necrosis factors
 Hepatocellular-like viral hepatitis features of liver
injury & inflammation predominate
 Cholestatic(obstructive)-gall stones,biliary
cirrhosis ,features of inhibition of bile flow
predominate
 Mixed -both feature are presents
 Etiologic diagnosis
 Estimation of disease sevearity (grading)
 Estimation of disease stage
 Family history – jaundice, anaemia, splenectomy,
cholecystectomy,gall stones
 Occupation in detail
 Environmental factor – contacts with rats (weils
diseases), exposures to toxins
 Travel to other countary
 Alcohol intake
 Conact with jaundice patients
 BT, plasma transfusion ,tattoing, dental treatment
 Drug history – narcotics, estrogens
 Indigestion or pain in rt upper quadrant
 A patient of liver dysfunction presents with following
complaints:
• Pain in abdomen-the rt. quadrant region
• Abdominal distension
• Pruritus
• Anorexia
• Nausea and vomiting
• Wt. loss
• Fever
• Fatigue
• Haematemesis
• Malaena
• Dark coloured urine (yellowish discolouration)
• White colour stool
• Oliguria
 Jaundice
 Hepatomegaly
 Spider Naevi
 Splenomegaly
 Scratch Marks
 Ascites
 Palmer Erythema
 Dilated Abdominal
Veins
 Peripheral Oedema
 Finger Clubbing
 Testicular Atrophy
 Bruising
 Gynaecomastia
 Confusion/Coma
 Jaundice in sclera or in skin
 Pallar –sign of anaemia(hemolysis)
 Gynecomastia , testicular atrophy (cirrhosis)
 Skin exam- ecchymosis due to prothombin
defficiency, purpura due to
thrombocytopenia,spidor angiomas found around
face neck shoulder forearm
 In chronic cholestatic – scratch marks , finger
clubbing
 Slight deterioration of the intellact &minimal
personality changes may suggest hepatocellular
disease
 Ascitis
 Dilatation of periumblical veins
 Size of liver
 Tender gall bladder (murphy sign)
 Auscultation – venous hum over dilated collatral
veins radiating from umblicus called caput
medusac
 Typical battary of blood test used for initial assesment of
liver disease
.Serum alanine aminotranferase (ALT) 5-42u/l
.Serum aspartate aminotransferase (AST) 5-40u/l
.Alkaline phosphatase
Children 25-350 u/l
Adult males 25-120 u/l
Adult females 25-90 u/l
.Direct (conjugated 0-0.2mg/dl)
. Total bilirubin (0.3 -1.0 mg/dl)
.Albumin 3.5-5.0 gm/dl
.Prothrombin time 11-15 secs
.Gamma glutamyl transpeptidase (GTT)
male-upto 40u/l
female-upto 25u/l
.Hepatitis serology to define types of viral hepatitis
 .autoimmune markers to diagnose primary biliary
cirrhosis (anti mitochondrial antibody AMA)
 Selerosing cholongitis(peripheral antineutrophil
cytoplasmic antibody P-ANCA)
 Autoimmune hepatitis (antinuclear ,smooth
muscle, liver kidney microsomal antibody)
Serum bilirubin: Bilirubin is a break down product of
the porphyrin ring of heme containing protein found in
two fraction
1. Conjugated(direct) : water soluble and can be
excreted by kidneys. Upto 30% of total bilirubin.
Increased due to liver or billiary tree disease.
2. Un- conjugated: Insoluble in water and bound to
albumin in blood.Increased due to haemolatic disorder
 Urine bilirubin: unconjugated bilirubin always bind
with albumin so it is not filtered by kidneys only
conjugated bilirubin is found in urine
 A urine dipstick test is done for urine conjugated
bilirubin
Ammonia is produced in the body during protein
metabolism liver ditoxifies it and convert to urea
There is a poor corelation of blood ammonia and
hepatic function as striated muscles also detoxifies
ammonia
Ammonia can be elevated in severe portal htn
 1. Enzymes reflects the damage to hepatocytes:
 AST is found in liver,cardiac muscle, skeletol
muscle,kidney,brain,lungs,leucocytes and
erythrocytes in decreasing order of concentration.
 ALT is found primarily in liver
 These enzymes released in blood in increased
amount when liver cells are damaged resulting
increase in permiability of cell membrane.
 There is a poor corelation between degree of liver
cell damaged and level of enzymes
 Level upto 300u/l are non-specific and may be
found in any type of liver disorder
 Level upto more than 1000u/l are specific and
extensive hepatocellular injury may present
 In most acute hepatocellular disorder the ALT is
higher than or equal to AST
 A ratio of AST:ALT 3:1 is suggestive of ALD
 The AST/ALT ratio is helpful in distinguishing
between alcohol induced hepatitis and viral
hepatitis.
 Alcohol tends to damage hepatocyte
mitochondria thus causing rise in AST usually
greater than twice the ALT.
 ALT activity is low in patients with alcohol
induced liver disease as these have
deficiencies of pyridoxal-5- phosphate, a
vitamin necessary for the function of ALT.
 A decrease in AST/ALT <1 ratio is more
consistent with a diagnosis of viral hepatitis.
 ALT-cytosol
 AST- mitochondria and cyotsol
 LDH- cytosol
 ALD- canalicular surface
 GGT-canalicular surface and microsomes
 5 NT-canalicular surface
 Cytoplasmic damage- increased AST,ALT,LDH
 Mitochondrial damage-increased AST
 Cholestatic damage-increased ALP AND GGT
 1.SERUM ALBUMIN: exclusively synthesized by
hepatocytes,long half life 15-20 days, poor
indicator for acute of chronic hepatic dysfunction
 Minimal changes seen in viral hepatitis, drug
related hepatotoxicity and obstructed jaundice.
 Hypo albuminemia is commom in cirrhosis
 2. SERUM GLOBULIN: Group of protein made up
of gamma globulin(immuno globulin).
 Produced by B lymphocytes and alpha and beta
globulin produced in hepatocytes
 Gama globulin increased in chronic liver disease
 Except factor VIII all blood coagulation factors are
made in liver hepatocytes
 Measurement of clotting factor is accurate
measure of hepetic synthetic function
 Serum prothrombine time measures factor II,V,VII
and X
 PT may be increased in vit.K deficiency
 PT more than 5 secs. Is poor prognostic sign in
hepatic disease
Test Obstructive Parenchymal
AST and ALT
Alkaline phosphatase
Albumin N
Prothrombin time N
Bilirubin N N
GGT
5’ Nucleotidase N
 Xray- limited role detects calcified & gas containg
lesions
 Barium studies of GIT
-In suspected cases of portal HTN to determine
esophagogastric varices.
-enlargement of lt. lobe of liver(due to tumour, abscess
or cirrhosis) may displace the barium filled stomach
laterally and anteriorly.
-tumours of the head of pancreas may produce
displacement or irregularity of 2nd
part of duodenum.
 USG whole abdomen
-to know the size and shape of liver and spleen.
-in biliary obstruction, to determine the size of bile
ducts, presence of gall stones, presence of mass in
the head of pancreas.
-in detecting mass lesions such as tumours, cysts or
liver abscess.
 CT- Abdomen & MRI
-in diagnosis of mass lesions in liver or pancreas.
-in differentiating intrahepatic fluid collections such as
cysts, abscesses and haematomas.
-to obtain excellent image of pancreas,liver and
 Magnetic resonance cholengiopancreatiography
(MRCP) for visualization of billary tree
 Endoscopic retrograde cholengiopancreatiography
(ERCP)-allows for biopsy,direct visualisation of
the ampulla and common bile duct having some
therapeutic options like sphincterotomy,stone
extraction,placement of nasobillary catheter and
biliary stents
 Percutaneous transhepatic cholangiography
(THC) – Percutaneous injection of contrast into
bile duct under fluoroscopic guidance can
determine sight and cause of billary obstruction
 Paul Ehrich performed first percutaneous liver
biopsy in 1883 in Germany.
 TYPES
 1. Percutaneous liver biopsy
 a) blind liver biopsy
 b) guided liver biopsy
 c) plugged liver biopsy
 2. Transvenous(trans jugular liver biopsy)
 3. Laproscopic liver biopsy
 Acute hepatitis of unknown cause
 Chronic liver disease
 a)to define cause
 b) grading of inflammatory activity
 c) staging of chronic hepatitis c and chronic
 hepatitis b
 d) monitor response to therapy
 Diagnosis of metabolic liver disorder
 Diagnosis and grading of alchoholic liver disease
 Staging of advanced cases of primary billiary
cirrhosis
 Investigation of persistant abnormal and
unexplained LFT
 Investigation of PUO
 Diagnosis of focal hepatic lesion
 Histologic monitoring following liver
transplantation
 Unco-operative patient
 Extrahepatic biliary obstruction
 Bleeding diathesis or abnormal coagulation profile
 Tense ascites
 Hydatid cyst of liver
 Suspected hemangioma or other vascular tumor
 Amyloidosis
 French word jaune means yellow or icterus, yellow
discoloration of skin, sclera and mucous
membrane
 Clinically evident when serum bilirubin>2.0 mg/dl
 Main type of bilirubin increased in plasma
 Unconjugated>85%of total
 causes are hemolysis,resorption of large
hematoma,ineffective erythopoiesis,physiological
jaundice of new born ,
 Conjugated >50%of total
 causes are: hepatitis cirrhosis,
cholestasis,drugs(anabolic steroids, oral
contraceptis) ,toxins
 Mixed(conjugated+unconjugated)
 Conjugated bilirubin is 25-50% of total, viral or
alchohlic hepatitis
 Hemolytic
 Hepatocellular
 Obstructive
 Pre-hepatic: Excessive formation of bilirubin
exceeding the capacity of the liver to conjugate it
for excretion. The type of bilirubin increased is
unconjugated.Urobilinogen is increased in urine
and feces
 Hepatic: Unconjugated, conjugated or both are
increased.
 Un conjugated: 1)Defective uptake of bilirubin by
liver cell from blood (gilbert’s syndrome). 2)
Defective conjugation of bilirubin
 Conjugated hyperbilirubenemia: 1)Hepatocellular
disease : AST and ALT are raised
 2) Intrahepatic cholestasis
 a) Impairment of secretion of bilirubin from
hepatocyte into biliary canaliculi
 b) Obstruction of bile flow in canaliculi by
swollen hepatocytes.
 c) Damage to intrahepatic canaliculi
 3) Post hepatic jaundice called as obstructive
surgical or extrahepatic cholestatic
 Child-Turcotte Pugh classification is a universally used
method developed in 1964.
 Total score=15(minimum=3)
 Grades= A,B,C
 Grade A(score of 5-6)-low risk with 5% mortality.
 Grade B(score of 7-9)-moderate risk with 10% mortality.
 Grade C(score of >10)-high risk with >50% mortality.
NB: grade C indicates decompensated cirrhosis.
Factor 1 2 3
1)Ser. bilirubin <2mg/dl 2-3mg/dl >3mg/dl
2)Ser.albumin >3.5g/dl 3-3.5g/dl <3gm/dl
3)Prothrombin time
a)Prolongation in sec. 0-4sec 4-6sec >6sec
b)INR <1.7 1.7-2.3 >2.3
4)Ascites none slight to tense
moderate
5)Hepatic
encephalopathy none minimal advanced
(grade I/II) (gradeIII/IV)
 Model for end stage liver disease(MELD) is another
system to assess the severity of liver disease which
was developed at Mayo clinic to assess 3 month
outcomes of patients undergoing TIPS(transjugular
intrahepatic portosystemic shunt procedure).
 Calculation is done by MELD Score:
=(0.957xlog e[serum creatinine(mg/dl)]+0.378 x log
e[total serum bilirubin(mg/dl)]+1.120 x log e[INR])
x10
 Minimum for all value=1
 Maximum value for creatinine=4
 A day prior to surgery, the anaesthetist should
meet the patient and relatives and explain about
the risk factors of surgery.
 Any expected post-operative ventilatory support
monitoring and about possible post-operative
complications should be explained to patient
and relatives.
 Consent
 Availability of appropriate blood and blood
products and suitable post-operative facilities to
be checked.
 Anti-anxiety medication is prescribed a night prior
to surgery in a guarded dose as there is reduced
ability of the liver to metabolize the drug.
 Patient to be kept NBM a night prior to surgery but
during this period IVF(crystalloids) in a rate of 1-
2ml/kg/hr is to be given as these patient who are
having jaundice and with hepatorenal syndrome are
at increase risk of renal damage if they become
dehydrated or hypotensive as a result of pre-op fast
as these concentrates toxins in the filtrate.
 Dextrose containing fluids is a better choice to
give when the patient is NBM as these pt. of
hepatic dysfunction are more prone for
hypoglycemia.
(Liver acts as a glucostat i.e. maintains blood
sugar level by glycogenesis and stopping
glycogenolysis when there is increased blood
sugar in blood and viceversa when there is
decrease blood sugar).
 The pre-operative risk factors associated with
increase post-operative mortality includes-
1)Serum albumin <3gm/dl
2)Presence of infection
3)WBC >10,000 cells/cubic mm
4)Treatment with more than 2 antibiotics.
5)Prothrombin time >1.5 sec over control.
6)Serum bilirubin >50µmol./litre(2.92mg/dl)
7)Presence of ascites
8)Malnutriion
9)Emergency surgery
 Regional anaesthesia is preferred in peripheral
surgeries if there is no clotting abnormalities.
Guidelines:
1)Prothrombin time not greater than 2.5sec. above the
lab. control
2)Platelet count >50,000/mm3
3)Bleeding time not greater than 12 min.
 If bleeding/clotting variables are within these
measurements epidural, spinal and regional block
anaesthesia can be employed.
 For abdominal surgeries/ pt. with obvious
coagulopathy, regional anaesthesia is contraindicated.
 Premedication-lorazepam(25-50 mck/kg)+
ranitidine
 Induction – thiopentone (3-5 mg/kg)
 Intubation-succinylcholine (1-2 mg/kg) and low
pressure cuffed oral tracheal tube
 Maintenance-fentanyl 1 mck/kg, isoflurane,O2,
N2O/air,ippv+peep(aim for paco2 3.5-4.6 pka)
 Drug infusion- atracurium 0.5 mg/kg per hr
 Venous access – peripheral cannulae
 Arterial line-central venous line (two) one for
monitoring one for drug infusion
 Urinary catheter – for urine output
Liver function test

More Related Content

What's hot

Circle system low flow anesthesia
Circle system low flow anesthesiaCircle system low flow anesthesia
Circle system low flow anesthesiaDrgeeta Choudhary
 
Desflurane
DesfluraneDesflurane
DesfluraneSun City
 
Mapleson breathing systems
Mapleson breathing systemsMapleson breathing systems
Mapleson breathing systemsdrdeepak016
 
Capnography
CapnographyCapnography
Capnographylarryide
 
Neuromuscular Monitoring
Neuromuscular MonitoringNeuromuscular Monitoring
Neuromuscular MonitoringMohtasib Madaoo
 
Invasive blood pressure_monitoring
Invasive blood pressure_monitoringInvasive blood pressure_monitoring
Invasive blood pressure_monitoringUbaidur Rahaman
 
Anaesthesia Vaporizers
Anaesthesia VaporizersAnaesthesia Vaporizers
Anaesthesia VaporizersRahul Varshney
 
Coronary circuln 07 02-2012
Coronary  circuln 07 02-2012Coronary  circuln 07 02-2012
Coronary circuln 07 02-2012Imran Sheikh
 
Anesthesia in Transurethral resection of prostate
Anesthesia in Transurethral resection of prostateAnesthesia in Transurethral resection of prostate
Anesthesia in Transurethral resection of prostateAshish Dhandare
 
ASRA Guidelines 4th Edition
ASRA Guidelines 4th EditionASRA Guidelines 4th Edition
ASRA Guidelines 4th EditionDr Krunal Bhatt
 
Anaesthetic problems of open chest and pathophysiology of one lung ventilation
Anaesthetic problems of open chest and pathophysiology of one lung ventilation Anaesthetic problems of open chest and pathophysiology of one lung ventilation
Anaesthetic problems of open chest and pathophysiology of one lung ventilation aratimohan
 
High pressure system- Anaesthesia Machine
High pressure system- Anaesthesia MachineHigh pressure system- Anaesthesia Machine
High pressure system- Anaesthesia MachineDr.Daber Pareed
 
Recruitment maneuvers in ards
Recruitment maneuvers in ardsRecruitment maneuvers in ards
Recruitment maneuvers in ardsAnusha Jahagirdar
 
DIABETES AND ITS ANAESTHETIC IMPLICATIONS
DIABETES AND ITS ANAESTHETIC IMPLICATIONSDIABETES AND ITS ANAESTHETIC IMPLICATIONS
DIABETES AND ITS ANAESTHETIC IMPLICATIONSSelva Kumar
 
Mapleson circuits
Mapleson circuitsMapleson circuits
Mapleson circuitsArun Shetty
 
O2 cascade flux n odc
O2 cascade flux n odcO2 cascade flux n odc
O2 cascade flux n odcRony Mathew
 

What's hot (20)

Propofol
PropofolPropofol
Propofol
 
Circle system low flow anesthesia
Circle system low flow anesthesiaCircle system low flow anesthesia
Circle system low flow anesthesia
 
Desflurane
DesfluraneDesflurane
Desflurane
 
Mapleson breathing systems
Mapleson breathing systemsMapleson breathing systems
Mapleson breathing systems
 
Capnography
CapnographyCapnography
Capnography
 
Neuromuscular Monitoring
Neuromuscular MonitoringNeuromuscular Monitoring
Neuromuscular Monitoring
 
Invasive blood pressure_monitoring
Invasive blood pressure_monitoringInvasive blood pressure_monitoring
Invasive blood pressure_monitoring
 
Anaesthesia Vaporizers
Anaesthesia VaporizersAnaesthesia Vaporizers
Anaesthesia Vaporizers
 
Coronary circuln 07 02-2012
Coronary  circuln 07 02-2012Coronary  circuln 07 02-2012
Coronary circuln 07 02-2012
 
Anesthesia in Transurethral resection of prostate
Anesthesia in Transurethral resection of prostateAnesthesia in Transurethral resection of prostate
Anesthesia in Transurethral resection of prostate
 
ASRA Guidelines 4th Edition
ASRA Guidelines 4th EditionASRA Guidelines 4th Edition
ASRA Guidelines 4th Edition
 
Anaesthetic problems of open chest and pathophysiology of one lung ventilation
Anaesthetic problems of open chest and pathophysiology of one lung ventilation Anaesthetic problems of open chest and pathophysiology of one lung ventilation
Anaesthetic problems of open chest and pathophysiology of one lung ventilation
 
Anaesthesia for LSCS
Anaesthesia for LSCSAnaesthesia for LSCS
Anaesthesia for LSCS
 
supraglottic airway devices
supraglottic airway devicessupraglottic airway devices
supraglottic airway devices
 
High pressure system- Anaesthesia Machine
High pressure system- Anaesthesia MachineHigh pressure system- Anaesthesia Machine
High pressure system- Anaesthesia Machine
 
Recruitment maneuvers in ards
Recruitment maneuvers in ardsRecruitment maneuvers in ards
Recruitment maneuvers in ards
 
DIABETES AND ITS ANAESTHETIC IMPLICATIONS
DIABETES AND ITS ANAESTHETIC IMPLICATIONSDIABETES AND ITS ANAESTHETIC IMPLICATIONS
DIABETES AND ITS ANAESTHETIC IMPLICATIONS
 
Oxygen transport
Oxygen transport Oxygen transport
Oxygen transport
 
Mapleson circuits
Mapleson circuitsMapleson circuits
Mapleson circuits
 
O2 cascade flux n odc
O2 cascade flux n odcO2 cascade flux n odc
O2 cascade flux n odc
 

Viewers also liked

Liver function test(lft) 09.05.16
Liver function test(lft)  09.05.16Liver function test(lft)  09.05.16
Liver function test(lft) 09.05.16Shahid Nawaz
 
Liver function test
Liver function testLiver function test
Liver function testGavin Yap
 
LIVER FUNCTION TESTS (LFT)
LIVER FUNCTION TESTS (LFT)LIVER FUNCTION TESTS (LFT)
LIVER FUNCTION TESTS (LFT)YESANNA
 
Liver function tests
Liver function testsLiver function tests
Liver function testsEkta Jajodia
 
02.01.12(b): Liver Tests - Use and Interpretation
02.01.12(b): Liver Tests - Use and Interpretation02.01.12(b): Liver Tests - Use and Interpretation
02.01.12(b): Liver Tests - Use and InterpretationOpen.Michigan
 
Liver function tests
Liver function testsLiver function tests
Liver function testsRishabh Gupta
 
APPROACH TO ABNORMAL LFT
APPROACH TO ABNORMAL LFTAPPROACH TO ABNORMAL LFT
APPROACH TO ABNORMAL LFTNavas Shareef
 
LIVER FUNCTION TEST (ENZYME PART)
LIVER FUNCTION TEST (ENZYME PART)LIVER FUNCTION TEST (ENZYME PART)
LIVER FUNCTION TEST (ENZYME PART)Yaalok
 
LIVER FUNCTION TEST
LIVER FUNCTION TESTLIVER FUNCTION TEST
LIVER FUNCTION TESTYaalok
 
Liver Function Tests
Liver Function TestsLiver Function Tests
Liver Function TestsBadhri Nath
 
Abnormal liver function tests
Abnormal liver function testsAbnormal liver function tests
Abnormal liver function testsAhmed Adel
 
Liver function tests and interpretation
Liver function tests and interpretation Liver function tests and interpretation
Liver function tests and interpretation subramaniam sethupathy
 

Viewers also liked (20)

Liver function test(lft) 09.05.16
Liver function test(lft)  09.05.16Liver function test(lft)  09.05.16
Liver function test(lft) 09.05.16
 
Liver Function Test
Liver Function TestLiver Function Test
Liver Function Test
 
Liver function test
Liver function testLiver function test
Liver function test
 
Liver function test
Liver function testLiver function test
Liver function test
 
LIVER FUNCTION TESTS (LFT)
LIVER FUNCTION TESTS (LFT)LIVER FUNCTION TESTS (LFT)
LIVER FUNCTION TESTS (LFT)
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
 
Liver Function Test
Liver Function TestLiver Function Test
Liver Function Test
 
Liver function test
Liver function testLiver function test
Liver function test
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
 
Liver function test
Liver function testLiver function test
Liver function test
 
02.01.12(b): Liver Tests - Use and Interpretation
02.01.12(b): Liver Tests - Use and Interpretation02.01.12(b): Liver Tests - Use and Interpretation
02.01.12(b): Liver Tests - Use and Interpretation
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
 
Liver function test
Liver function testLiver function test
Liver function test
 
APPROACH TO ABNORMAL LFT
APPROACH TO ABNORMAL LFTAPPROACH TO ABNORMAL LFT
APPROACH TO ABNORMAL LFT
 
LIVER FUNCTION TEST (ENZYME PART)
LIVER FUNCTION TEST (ENZYME PART)LIVER FUNCTION TEST (ENZYME PART)
LIVER FUNCTION TEST (ENZYME PART)
 
LIVER FUNCTION TEST
LIVER FUNCTION TESTLIVER FUNCTION TEST
LIVER FUNCTION TEST
 
Liver Function Tests
Liver Function TestsLiver Function Tests
Liver Function Tests
 
Abnormal liver function tests
Abnormal liver function testsAbnormal liver function tests
Abnormal liver function tests
 
Liver function tests and interpretation
Liver function tests and interpretation Liver function tests and interpretation
Liver function tests and interpretation
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
 

Similar to Liver function test

Hepatic physiology & liver function tests
Hepatic physiology & liver function testsHepatic physiology & liver function tests
Hepatic physiology & liver function testsImran Sheikh
 
Anatomy & physiology of liver
Anatomy & physiology of liverAnatomy & physiology of liver
Anatomy & physiology of liverAnit Kumar Mondal
 
LIVER FUNCTION TESTS from Millers Anesthesia
LIVER FUNCTION TESTS from Millers Anesthesia LIVER FUNCTION TESTS from Millers Anesthesia
LIVER FUNCTION TESTS from Millers Anesthesia CharanKamal11
 
Upper GI Bleeding (Liver and Spleen) Bambury
Upper GI Bleeding (Liver and Spleen) BamburyUpper GI Bleeding (Liver and Spleen) Bambury
Upper GI Bleeding (Liver and Spleen) BamburyJeku Jacob
 
Function of the liver
Function of the liverFunction of the liver
Function of the liverAdil Rahimli
 
INTERGRATED RESPONSE TO A MEAL V. INTESTINAL PHASE (ii)
INTERGRATED RESPONSE TO A MEAL V. INTESTINAL PHASE (ii)INTERGRATED RESPONSE TO A MEAL V. INTESTINAL PHASE (ii)
INTERGRATED RESPONSE TO A MEAL V. INTESTINAL PHASE (ii)SAMOEINESH
 
Liver function tests
Liver function testsLiver function tests
Liver function testslaxman wagle
 
Anaesthesia and liver_disease
Anaesthesia and liver_diseaseAnaesthesia and liver_disease
Anaesthesia and liver_diseaseShahZaib134
 
Liver anatomy and physiology
Liver anatomy and physiologyLiver anatomy and physiology
Liver anatomy and physiologyHimanshu Jangid
 
Hepatic physiology
Hepatic physiology Hepatic physiology
Hepatic physiology Waquas Ahmed
 
vdocuments.net_function-of-the-liver.ppt
vdocuments.net_function-of-the-liver.pptvdocuments.net_function-of-the-liver.ppt
vdocuments.net_function-of-the-liver.pptDineshPatra15
 

Similar to Liver function test (20)

Hepatic physiology & liver function tests
Hepatic physiology & liver function testsHepatic physiology & liver function tests
Hepatic physiology & liver function tests
 
Liver Disease
Liver DiseaseLiver Disease
Liver Disease
 
Anatomy & physiology of liver
Anatomy & physiology of liverAnatomy & physiology of liver
Anatomy & physiology of liver
 
LIVER FUNCTION TESTS from Millers Anesthesia
LIVER FUNCTION TESTS from Millers Anesthesia LIVER FUNCTION TESTS from Millers Anesthesia
LIVER FUNCTION TESTS from Millers Anesthesia
 
Liver & Liver Diseases
Liver &  Liver DiseasesLiver &  Liver Diseases
Liver & Liver Diseases
 
Upper GI Bleeding (Liver and Spleen) Bambury
Upper GI Bleeding (Liver and Spleen) BamburyUpper GI Bleeding (Liver and Spleen) Bambury
Upper GI Bleeding (Liver and Spleen) Bambury
 
Function of the liver
Function of the liverFunction of the liver
Function of the liver
 
INTERGRATED RESPONSE TO A MEAL V. INTESTINAL PHASE (ii)
INTERGRATED RESPONSE TO A MEAL V. INTESTINAL PHASE (ii)INTERGRATED RESPONSE TO A MEAL V. INTESTINAL PHASE (ii)
INTERGRATED RESPONSE TO A MEAL V. INTESTINAL PHASE (ii)
 
HEPATOLOGY
HEPATOLOGYHEPATOLOGY
HEPATOLOGY
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
 
Hepatitis C
Hepatitis CHepatitis C
Hepatitis C
 
Anaesthesia and liver_disease
Anaesthesia and liver_diseaseAnaesthesia and liver_disease
Anaesthesia and liver_disease
 
Cirrhosis of liver
Cirrhosis of liverCirrhosis of liver
Cirrhosis of liver
 
Final lecture
Final lectureFinal lecture
Final lecture
 
Liver anatomy and physiology
Liver anatomy and physiologyLiver anatomy and physiology
Liver anatomy and physiology
 
Structure and functions of liver
Structure and functions of liverStructure and functions of liver
Structure and functions of liver
 
Hepatic physiology
Hepatic physiology Hepatic physiology
Hepatic physiology
 
liver 1-27.6.2014.ppt
liver 1-27.6.2014.pptliver 1-27.6.2014.ppt
liver 1-27.6.2014.ppt
 
vdocuments.net_function-of-the-liver.ppt
vdocuments.net_function-of-the-liver.pptvdocuments.net_function-of-the-liver.ppt
vdocuments.net_function-of-the-liver.ppt
 
alcoholicliverdisease.pptx
alcoholicliverdisease.pptxalcoholicliverdisease.pptx
alcoholicliverdisease.pptx
 

More from dr anurag giri

More from dr anurag giri (20)

Spinal anesthesia
Spinal anesthesiaSpinal anesthesia
Spinal anesthesia
 
Spinal anesthesia
Spinal anesthesiaSpinal anesthesia
Spinal anesthesia
 
Monitoring depth of anaesthesia
Monitoring depth of anaesthesiaMonitoring depth of anaesthesia
Monitoring depth of anaesthesia
 
Vinayak atropine glyco
Vinayak atropine glycoVinayak atropine glyco
Vinayak atropine glyco
 
Thiopentone upendra
Thiopentone upendraThiopentone upendra
Thiopentone upendra
 
The autonomic nervous system and its implications in
The autonomic nervous system and its implications inThe autonomic nervous system and its implications in
The autonomic nervous system and its implications in
 
Spinal, dalal madam
Spinal, dalal madamSpinal, dalal madam
Spinal, dalal madam
 
Soares ans
Soares ansSoares ans
Soares ans
 
Pac premedication -dr.vaidya
Pac  premedication  -dr.vaidyaPac  premedication  -dr.vaidya
Pac premedication -dr.vaidya
 
L a agents
L a agentsL a agents
L a agents
 
Ketamine poonam
Ketamine poonamKetamine poonam
Ketamine poonam
 
Ans physiology
Ans physiologyAns physiology
Ans physiology
 
Soares ans
Soares ansSoares ans
Soares ans
 
Pathophysio of pain
Pathophysio of painPathophysio of pain
Pathophysio of pain
 
Pac premedication -dr.vaidya
Pac  premedication  -dr.vaidyaPac  premedication  -dr.vaidya
Pac premedication -dr.vaidya
 
Airway anatomy
Airway anatomyAirway anatomy
Airway anatomy
 
L a agents
L a agentsL a agents
L a agents
 
Ketamine poonam
Ketamine poonamKetamine poonam
Ketamine poonam
 
Ecg 1
Ecg 1Ecg 1
Ecg 1
 
Ans physiology
Ans physiologyAns physiology
Ans physiology
 

Liver function test

  • 1. GUIDED BY : DR. C. GADKARI MAM PRESENTED BY : DR. ANURAG GIRI
  • 2.
  • 3.  Located in rt upper quadrant of the abdomen under right lower rib cage and projects for a variable extent into left upper quadrant  Held in place by ligamentous attachment to the diphram, peritonium ,great vessles and upper GI track.  Rt lobe further divided into: 1. CAUDATE POSTERIOR SURFACE  2. QUADRATE INFERIOR SURFACE  Liver is divided into 8 segments
  • 4.  Largest internal organ and body’s metabolic headquarter  Wt. 1.5kg (2%)of total body weight of adult
  • 5.
  • 6.  Liver receives 25% of cardiac output via dual supply (portal vein and hepatic artery)  Portal vein drains blood from GI track and supply 75% of liver inflow (1L/min)  Hepatic artery supply 25%  Due to high O2 contents in hepatic artery each vessel supply 50% of hepatic O2  Portal vein have low vascular resistance (8-10mm/hg)  Hepatic venous pressure is 0 mm/hg
  • 7.
  • 8.  Functional unit Is lobule (1x2mm). 50,000- 1,00,000  Lobule consists of plates of hepatocytes located in a radial distribution about a central vein  Efferent blood supply from portal vein and hepatic arterey enters at periphery of lobule  Bile formed in the hepatocytes flows into canaliculi (located between plates of hepatocytes) and drains to the bile duct
  • 9.  The large pores in the endothelium lining are sinusoids lined by two types of cell : typical endothelial cells and large kupffer cells(reticulo endothelial) capable of pagocytizing bacteria and other foreign matter in the blood. Allow plasma and its protein to move into the tissue space surrounding hepatocytes (space of dissc) This fluid drains into the lymphatic system
  • 10.
  • 11.  Microcirculation of liver lobule  ZONE 1: PERIPORTEL : Receive O2 rich blood from portal vein and hepatic artery.  ZONE 2: MEDIOLOBULAR : As blood moves through sinusoid it passes from zone 2 to zone 3.  ZONE 3: CENTRILOBULAR : Poor in O2
  • 12.  Sympathetic innervation from T3 to T11 controls resistance in hepatic venules  When injured hepatocytes turns into fibrous tissue blood flow is impeded and causes portal hypertension  When portal venous flow is reduced the hepatic atrery can increase flow by 100% to maintain hepatic O2 supply.This relation between two vesseles is hepatic artrial buffer response
  • 13. FUNCTION DETAILS ANAESTHETIC RELEVANCE BLOOD RESERVOIR 10-15% of total blood volume Anaesthetics supress sympathetic tone BLOOD COAGULATION Synt of pro and anticlotting.vit K absorption depends on bile excretion. Thrombopoietin modulates platelet production Coagulopathies lead to increased perioperative bleeding ENDOCRINE CONTROL Syn & secretes Insuline like growth factor1,angiotensin, Thyroxine binding globulin Converts T4 to T3. inactivates: corticosteroids, aldosteron, estrogen, androgen, insulin, ADH Perioperative endocrine abnormalities
  • 14. BILIRUBIN EXCRETION Absorbs bilirubin from blood,conjugates and excretes.synthesizes haptoglobin and scavenges Hb Lipid metabolism Fatty acid synthesis, cholesterol and lipoprotein metabolism Abnormal cellular function, affect pharmacokinetic and dynamics of anaesthetic agents. Amino acid metabolism Protein and aminoacid metabolism and urea production Elevated level and encephalopathy Immunologic modulation Largest reticuloendothelial organ. Filters out toxins, bacteria and debris. Hepatic macrophages,Tcells and Kupffer cells triggers systemic inflammatory Immunocompromise susceptible to perioperative infection and sepsis.
  • 15.  Liver can store 1L of blood and release blood in circulation at low blood volume  Liver stores vit.B12 (1yr supply)  vit.D (3mnth supply)  vit.A (10mnth supply)  Iron transported via apoferrin and stored as ferritin (blood iron buffer
  • 16.  Energy production and storage of nutrients absorbed from GI track  Glucose buffering function : Store glucose as glycogen convert carbohydrate (fructose and glactose) to glucose  Synthesise glucose from amino acid and triglicerides (gluconeogenesis)  Synthesise fat cholesterol phospholipids and lipo proteins
  • 17.  Metabolise fat,convert fatty acid to acetyl coenzyme A (COA) is excellent source of energy  Cholestrol synthesized is converted to bile salt and secreted to bile,rest is distributed to body to form cellular membrane and other vital structure
  • 18.  Protein metabolism synthesize all plasma protein except gama globolins (which are formed in plasma cell)  Forms 15-50gms protein/day  Albumin is the major protein synthesized and responsible for plasma oncotic pressure
  • 19.  Blood clotting factors  Synthesize in liver except factor III (tissue thromboplastin), factor IV (calcium) and factor VIII (von willbrand)  Vit K is required for synthesis of factor II (prothombin),factor VII , IX , X  Produce around 500ml of bile daily and store in gall bladder in concentrated form 35-50ml  The fat in food in the duodeneum causes release of choleystokenin hormone from duodenel mucose that stimulate gall bladder contraction
  • 20.  Bile contains bile salt,bilirubin and cholestrol.  It dissolves fat to absorb into GI track and bile salt returns to liver by portal vein
  • 21.
  • 22.  Liver has unique ability to regenerate  It restores itself after injury or partial hepatectomy  Hepatocytes growth factor produced by mesenchymal cells in the liver  Other growth factor are epidermal growth factor, interlukin-6,cytokines ,tumor necrosis factors
  • 23.  Hepatocellular-like viral hepatitis features of liver injury & inflammation predominate  Cholestatic(obstructive)-gall stones,biliary cirrhosis ,features of inhibition of bile flow predominate  Mixed -both feature are presents
  • 24.  Etiologic diagnosis  Estimation of disease sevearity (grading)  Estimation of disease stage
  • 25.  Family history – jaundice, anaemia, splenectomy, cholecystectomy,gall stones  Occupation in detail  Environmental factor – contacts with rats (weils diseases), exposures to toxins  Travel to other countary  Alcohol intake  Conact with jaundice patients  BT, plasma transfusion ,tattoing, dental treatment
  • 26.  Drug history – narcotics, estrogens  Indigestion or pain in rt upper quadrant
  • 27.  A patient of liver dysfunction presents with following complaints: • Pain in abdomen-the rt. quadrant region • Abdominal distension • Pruritus • Anorexia • Nausea and vomiting • Wt. loss • Fever • Fatigue • Haematemesis • Malaena • Dark coloured urine (yellowish discolouration) • White colour stool • Oliguria
  • 28.  Jaundice  Hepatomegaly  Spider Naevi  Splenomegaly  Scratch Marks  Ascites  Palmer Erythema  Dilated Abdominal Veins  Peripheral Oedema  Finger Clubbing  Testicular Atrophy  Bruising  Gynaecomastia  Confusion/Coma
  • 29.  Jaundice in sclera or in skin  Pallar –sign of anaemia(hemolysis)  Gynecomastia , testicular atrophy (cirrhosis)  Skin exam- ecchymosis due to prothombin defficiency, purpura due to thrombocytopenia,spidor angiomas found around face neck shoulder forearm  In chronic cholestatic – scratch marks , finger clubbing
  • 30.  Slight deterioration of the intellact &minimal personality changes may suggest hepatocellular disease
  • 31.  Ascitis  Dilatation of periumblical veins  Size of liver  Tender gall bladder (murphy sign)  Auscultation – venous hum over dilated collatral veins radiating from umblicus called caput medusac
  • 32.  Typical battary of blood test used for initial assesment of liver disease .Serum alanine aminotranferase (ALT) 5-42u/l .Serum aspartate aminotransferase (AST) 5-40u/l .Alkaline phosphatase Children 25-350 u/l Adult males 25-120 u/l Adult females 25-90 u/l
  • 33. .Direct (conjugated 0-0.2mg/dl) . Total bilirubin (0.3 -1.0 mg/dl) .Albumin 3.5-5.0 gm/dl .Prothrombin time 11-15 secs .Gamma glutamyl transpeptidase (GTT) male-upto 40u/l female-upto 25u/l .Hepatitis serology to define types of viral hepatitis
  • 34.  .autoimmune markers to diagnose primary biliary cirrhosis (anti mitochondrial antibody AMA)  Selerosing cholongitis(peripheral antineutrophil cytoplasmic antibody P-ANCA)  Autoimmune hepatitis (antinuclear ,smooth muscle, liver kidney microsomal antibody)
  • 35. Serum bilirubin: Bilirubin is a break down product of the porphyrin ring of heme containing protein found in two fraction 1. Conjugated(direct) : water soluble and can be excreted by kidneys. Upto 30% of total bilirubin. Increased due to liver or billiary tree disease. 2. Un- conjugated: Insoluble in water and bound to albumin in blood.Increased due to haemolatic disorder
  • 36.  Urine bilirubin: unconjugated bilirubin always bind with albumin so it is not filtered by kidneys only conjugated bilirubin is found in urine  A urine dipstick test is done for urine conjugated bilirubin
  • 37. Ammonia is produced in the body during protein metabolism liver ditoxifies it and convert to urea There is a poor corelation of blood ammonia and hepatic function as striated muscles also detoxifies ammonia Ammonia can be elevated in severe portal htn
  • 38.  1. Enzymes reflects the damage to hepatocytes:  AST is found in liver,cardiac muscle, skeletol muscle,kidney,brain,lungs,leucocytes and erythrocytes in decreasing order of concentration.  ALT is found primarily in liver  These enzymes released in blood in increased amount when liver cells are damaged resulting increase in permiability of cell membrane.
  • 39.  There is a poor corelation between degree of liver cell damaged and level of enzymes  Level upto 300u/l are non-specific and may be found in any type of liver disorder  Level upto more than 1000u/l are specific and extensive hepatocellular injury may present  In most acute hepatocellular disorder the ALT is higher than or equal to AST  A ratio of AST:ALT 3:1 is suggestive of ALD
  • 40.  The AST/ALT ratio is helpful in distinguishing between alcohol induced hepatitis and viral hepatitis.  Alcohol tends to damage hepatocyte mitochondria thus causing rise in AST usually greater than twice the ALT.  ALT activity is low in patients with alcohol induced liver disease as these have deficiencies of pyridoxal-5- phosphate, a vitamin necessary for the function of ALT.  A decrease in AST/ALT <1 ratio is more consistent with a diagnosis of viral hepatitis.
  • 41.  ALT-cytosol  AST- mitochondria and cyotsol  LDH- cytosol  ALD- canalicular surface  GGT-canalicular surface and microsomes  5 NT-canalicular surface
  • 42.  Cytoplasmic damage- increased AST,ALT,LDH  Mitochondrial damage-increased AST  Cholestatic damage-increased ALP AND GGT
  • 43.  1.SERUM ALBUMIN: exclusively synthesized by hepatocytes,long half life 15-20 days, poor indicator for acute of chronic hepatic dysfunction  Minimal changes seen in viral hepatitis, drug related hepatotoxicity and obstructed jaundice.  Hypo albuminemia is commom in cirrhosis
  • 44.  2. SERUM GLOBULIN: Group of protein made up of gamma globulin(immuno globulin).  Produced by B lymphocytes and alpha and beta globulin produced in hepatocytes  Gama globulin increased in chronic liver disease
  • 45.  Except factor VIII all blood coagulation factors are made in liver hepatocytes  Measurement of clotting factor is accurate measure of hepetic synthetic function  Serum prothrombine time measures factor II,V,VII and X  PT may be increased in vit.K deficiency  PT more than 5 secs. Is poor prognostic sign in hepatic disease
  • 46. Test Obstructive Parenchymal AST and ALT Alkaline phosphatase Albumin N Prothrombin time N Bilirubin N N GGT 5’ Nucleotidase N
  • 47.  Xray- limited role detects calcified & gas containg lesions  Barium studies of GIT -In suspected cases of portal HTN to determine esophagogastric varices. -enlargement of lt. lobe of liver(due to tumour, abscess or cirrhosis) may displace the barium filled stomach laterally and anteriorly. -tumours of the head of pancreas may produce displacement or irregularity of 2nd part of duodenum.
  • 48.  USG whole abdomen -to know the size and shape of liver and spleen. -in biliary obstruction, to determine the size of bile ducts, presence of gall stones, presence of mass in the head of pancreas. -in detecting mass lesions such as tumours, cysts or liver abscess.  CT- Abdomen & MRI -in diagnosis of mass lesions in liver or pancreas. -in differentiating intrahepatic fluid collections such as cysts, abscesses and haematomas. -to obtain excellent image of pancreas,liver and
  • 49.  Magnetic resonance cholengiopancreatiography (MRCP) for visualization of billary tree  Endoscopic retrograde cholengiopancreatiography (ERCP)-allows for biopsy,direct visualisation of the ampulla and common bile duct having some therapeutic options like sphincterotomy,stone extraction,placement of nasobillary catheter and biliary stents
  • 50.  Percutaneous transhepatic cholangiography (THC) – Percutaneous injection of contrast into bile duct under fluoroscopic guidance can determine sight and cause of billary obstruction
  • 51.  Paul Ehrich performed first percutaneous liver biopsy in 1883 in Germany.  TYPES  1. Percutaneous liver biopsy  a) blind liver biopsy  b) guided liver biopsy  c) plugged liver biopsy  2. Transvenous(trans jugular liver biopsy)  3. Laproscopic liver biopsy
  • 52.  Acute hepatitis of unknown cause  Chronic liver disease  a)to define cause  b) grading of inflammatory activity  c) staging of chronic hepatitis c and chronic  hepatitis b  d) monitor response to therapy  Diagnosis of metabolic liver disorder  Diagnosis and grading of alchoholic liver disease
  • 53.  Staging of advanced cases of primary billiary cirrhosis  Investigation of persistant abnormal and unexplained LFT  Investigation of PUO  Diagnosis of focal hepatic lesion  Histologic monitoring following liver transplantation
  • 54.  Unco-operative patient  Extrahepatic biliary obstruction  Bleeding diathesis or abnormal coagulation profile  Tense ascites  Hydatid cyst of liver  Suspected hemangioma or other vascular tumor  Amyloidosis
  • 55.  French word jaune means yellow or icterus, yellow discoloration of skin, sclera and mucous membrane  Clinically evident when serum bilirubin>2.0 mg/dl
  • 56.  Main type of bilirubin increased in plasma  Unconjugated>85%of total  causes are hemolysis,resorption of large hematoma,ineffective erythopoiesis,physiological jaundice of new born ,  Conjugated >50%of total  causes are: hepatitis cirrhosis, cholestasis,drugs(anabolic steroids, oral contraceptis) ,toxins
  • 57.  Mixed(conjugated+unconjugated)  Conjugated bilirubin is 25-50% of total, viral or alchohlic hepatitis
  • 59.  Pre-hepatic: Excessive formation of bilirubin exceeding the capacity of the liver to conjugate it for excretion. The type of bilirubin increased is unconjugated.Urobilinogen is increased in urine and feces  Hepatic: Unconjugated, conjugated or both are increased.  Un conjugated: 1)Defective uptake of bilirubin by liver cell from blood (gilbert’s syndrome). 2) Defective conjugation of bilirubin
  • 60.  Conjugated hyperbilirubenemia: 1)Hepatocellular disease : AST and ALT are raised  2) Intrahepatic cholestasis  a) Impairment of secretion of bilirubin from hepatocyte into biliary canaliculi  b) Obstruction of bile flow in canaliculi by swollen hepatocytes.  c) Damage to intrahepatic canaliculi  3) Post hepatic jaundice called as obstructive surgical or extrahepatic cholestatic
  • 61.
  • 62.  Child-Turcotte Pugh classification is a universally used method developed in 1964.  Total score=15(minimum=3)  Grades= A,B,C  Grade A(score of 5-6)-low risk with 5% mortality.  Grade B(score of 7-9)-moderate risk with 10% mortality.  Grade C(score of >10)-high risk with >50% mortality. NB: grade C indicates decompensated cirrhosis.
  • 63. Factor 1 2 3 1)Ser. bilirubin <2mg/dl 2-3mg/dl >3mg/dl 2)Ser.albumin >3.5g/dl 3-3.5g/dl <3gm/dl 3)Prothrombin time a)Prolongation in sec. 0-4sec 4-6sec >6sec b)INR <1.7 1.7-2.3 >2.3 4)Ascites none slight to tense moderate 5)Hepatic encephalopathy none minimal advanced (grade I/II) (gradeIII/IV)
  • 64.  Model for end stage liver disease(MELD) is another system to assess the severity of liver disease which was developed at Mayo clinic to assess 3 month outcomes of patients undergoing TIPS(transjugular intrahepatic portosystemic shunt procedure).  Calculation is done by MELD Score: =(0.957xlog e[serum creatinine(mg/dl)]+0.378 x log e[total serum bilirubin(mg/dl)]+1.120 x log e[INR]) x10  Minimum for all value=1  Maximum value for creatinine=4
  • 65.  A day prior to surgery, the anaesthetist should meet the patient and relatives and explain about the risk factors of surgery.  Any expected post-operative ventilatory support monitoring and about possible post-operative complications should be explained to patient and relatives.  Consent  Availability of appropriate blood and blood products and suitable post-operative facilities to be checked.
  • 66.  Anti-anxiety medication is prescribed a night prior to surgery in a guarded dose as there is reduced ability of the liver to metabolize the drug.  Patient to be kept NBM a night prior to surgery but during this period IVF(crystalloids) in a rate of 1- 2ml/kg/hr is to be given as these patient who are having jaundice and with hepatorenal syndrome are at increase risk of renal damage if they become dehydrated or hypotensive as a result of pre-op fast as these concentrates toxins in the filtrate.
  • 67.  Dextrose containing fluids is a better choice to give when the patient is NBM as these pt. of hepatic dysfunction are more prone for hypoglycemia. (Liver acts as a glucostat i.e. maintains blood sugar level by glycogenesis and stopping glycogenolysis when there is increased blood sugar in blood and viceversa when there is decrease blood sugar).
  • 68.  The pre-operative risk factors associated with increase post-operative mortality includes- 1)Serum albumin <3gm/dl 2)Presence of infection 3)WBC >10,000 cells/cubic mm 4)Treatment with more than 2 antibiotics. 5)Prothrombin time >1.5 sec over control. 6)Serum bilirubin >50µmol./litre(2.92mg/dl) 7)Presence of ascites 8)Malnutriion 9)Emergency surgery
  • 69.  Regional anaesthesia is preferred in peripheral surgeries if there is no clotting abnormalities. Guidelines: 1)Prothrombin time not greater than 2.5sec. above the lab. control 2)Platelet count >50,000/mm3 3)Bleeding time not greater than 12 min.  If bleeding/clotting variables are within these measurements epidural, spinal and regional block anaesthesia can be employed.  For abdominal surgeries/ pt. with obvious coagulopathy, regional anaesthesia is contraindicated.
  • 70.  Premedication-lorazepam(25-50 mck/kg)+ ranitidine  Induction – thiopentone (3-5 mg/kg)  Intubation-succinylcholine (1-2 mg/kg) and low pressure cuffed oral tracheal tube  Maintenance-fentanyl 1 mck/kg, isoflurane,O2, N2O/air,ippv+peep(aim for paco2 3.5-4.6 pka)  Drug infusion- atracurium 0.5 mg/kg per hr  Venous access – peripheral cannulae  Arterial line-central venous line (two) one for monitoring one for drug infusion  Urinary catheter – for urine output